Surgery is the main treatment for gastric cancer

If gastric cancer treatment can be started in the early stages, many patients can be completely cured. According to the size of the tumor, appropriate resection surgery is the treatment method for early gastric cancer . With the level of modern medical technology, the success rate is also very high.

Due to the improvement of gastric cancer treatment, the indications for surgery have been expanded accordingly. At present, except for patients with huge and fixed primary lesions, extensive metastasis to abdominal organs, and cachexia with bloody ascites, as long as the patient's general condition permits, even if there are supraclavicular lymph node metastases and metastatic nodules in the liver, laparotomy should be performed to remove the primary lesion and alleviate symptoms. According to statistics of 11,734 gastric cancer surgeries in China, the surgical rate was 81.8% and the total resection rate was 49.7%. In recent years, the tumor resection rate has increased to about 75%, mainly due to the increase in the resection rate of stage II and III gastric cancer.

Immunotherapy can also be used to assist in the treatment of gastric cancer. The indications for immunotherapy include:

① Systemic immunostimulants are suitable for early gastric cancer after radical surgery;

② For cases that cannot be resected or require palliative resection, immunostimulants can be directly injected into the residual cancer;

③ Late-stage patients with ascites are suitable for intraperitoneal injection of immune-enhancing drugs.

The above is an introduction to the treatment of gastric cancer. It can be seen that with the support of modern medical technology, the treatment of gastric cancer is feasible, and the cure rate is increasing year by year. For the treatment of gastric cancer, the earlier it starts, the easier it is to completely cure it, so you must not delay treatment if you have gastric cancer.